Psoriasis Global Market Report 2022 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography. It covers the historic period – 2016-2021, and the forecast period – 2022-2026, with additional forecasts for 2026-2031. The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
TBRC’s market report
includes a chapter on the COVID-19 impact on the psoriasis industry, which gives
valuable insights on supply chain disruptions, logistical challenges, and other
economic implications of the virus on the market and how companies can strategize
to bounce back from it. With updated market numbers according to the effects of
the coronavirus, the report provides the most accurate expected psoriasis market
growth numbers from 2022-2031.
Request a Sample of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp
The global
psoriasis market size is expected to grow from $17.67 billion in 2021 to $19.98
billion in 2022 at a compound annual growth rate (CAGR) of 13.1%. The growth in
the market is mainly due to the companies rearranging their operations and
recovering from the COVID-19 impact, which had earlier led to restrictive
containment measures involving social distancing, remote working, and the
closure of commercial activities that resulted in operational challenges. The
global psoriasis market is expected to reach $30.90 billion in 2026 at a CAGR
of 11.5%.
View more on the report:
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report
The Psoriasis Global
Market Report 2022-31 by The Business Research Company evaluates psoriasis
market size, growth rate, drivers, psoriasis industry trends, and major
companies.
The psoriasis
market segments in the report are:
1) By Drug Class:
Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis
Factor Inhibitor
2) By
Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce
3) By Drug Type:
Small Molecules, Biologics
4) By Route of
Administration: Oral, Tropical, Injectable
5) By Disease
Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular
Psoriasis, Erythrodermic Psoriasis
The table of contents in TBRC’s psoriasis market report includes:
1. Executive
Summary
2. Psoriasis
Drugs Market Characteristics
3. Psoriasis
Drugs Market Trends And Strategies
4. Impact Of
COVID-19 On Psoriasis Drugs
5. Psoriasis
Drugs Market Size And Growth.
.
28. Psoriasis
Drugs Pipeline Analysis
29. Key Mergers
And Acquisitions In The Psoriasis Drugs Market
30. Psoriasis
Drugs Market Future Outlook and Potential Analysis
31. Appendix
About The Business Research Company:
The Business
Research Company is a market intelligence firm that excels in company, market,
and consumer research. Located globally it has specialist consultants in a wide
range of industries including manufacturing, healthcare, financial services,
chemicals, and technology. It has offices in the UK, the US and India and
a network of trained researchers in 20+ countries globally.
Get a quick
glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
No comments:
Post a Comment